The stock of Mira Pharmaceuticals Inc (MIRA) has gone up by 11.30% for the week, with a -21.76% drop in the past month and a -21.76% drop in the past quarter. The volatility ratio for the week is 12.86%, and the volatility levels for the past 30 days are 10.05% for MIRA. The simple moving average for the past 20 days is -4.39% for MIRA’s stock, with a -29.12% simple moving average for the past 200 days.
Is It Worth Investing in Mira Pharmaceuticals Inc (NASDAQ: MIRA) Right Now?
The stock has a 36-month beta value of 1.66. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for MIRA is 12.48M, and at present, short sellers hold a 4.61% of that float. On April 21, 2025, the average trading volume of MIRA was 1.03M shares.
MIRA) stock’s latest price update
Mira Pharmaceuticals Inc (NASDAQ: MIRA)’s stock price has dropped by -12.25 in relation to previous closing price of 1.07. Nevertheless, the company has seen a gain of 11.30% in its stock price over the last five trading days. accessnewswire.com reported 2025-04-16 that Ketamir-2 Demonstrates Strong Efficacy in Diabetic Neuropathy Model, with Some Subjects Achieving Complete Symptom Reversal MIAMI, FLORIDA / ACCESS Newswire / April 16, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), or MIRA, a clinical-stage pharmaceutical company focused on developing novel therapeutics for neurologic and neuropsychiatric disorders, today announced compelling data demonstrating the efficacy of the oral ketamine analog, Ketamir-2, in a validated animal model of diabetic neuropathy. In the study, Type 2 diabetes was induced in rats using a high-fat diet combined with a low dose of Streptozotocin (STZ).
MIRA Trading at -10.17% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -81.26% of loss for the given period.
Volatility was left at 10.05%, however, over the last 30 days, the volatility rate increased by 12.86%, as shares sank -23.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.76% lower at present.
During the last 5 trading sessions, MIRA rose by +11.77%, which changed the moving average for the period of 200-days by +42.47% in comparison to the 20-day moving average, which settled at $0.9820. In addition, Mira Pharmaceuticals Inc saw -17.64% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from Aminov Erez, who sale 55,410 shares at the price of $1.39 back on Nov 19 ’24. After this action, Aminov Erez now owns 1,105,790 shares of Mira Pharmaceuticals Inc, valued at $77,020 using the latest closing price.
Aminov Erez, the Chief Executive Officer of Mira Pharmaceuticals Inc, sale 44,590 shares at $1.27 during a trade that took place back on Nov 20 ’24, which means that Aminov Erez is holding 1,061,200 shares at $56,629 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -3.65. Equity return is now at value -238.90, with -199.93 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 3.99.
Conclusion
To sum up, Mira Pharmaceuticals Inc (MIRA) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
